Quadrant Capital Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4K Hold
688
﹤0.01% 2143
2025
Q4
$16.1K Hold
688
﹤0.01% 2069
2025
Q3
$13.7K Buy
+688
New +$12.4K ﹤0.01% 2071
2025
Q2
Sell
-1,340
Closed -$14.8K 2561
2025
Q1
$14.8K Buy
1,340
+1,314
+5,054% +$14K ﹤0.01% 2125
2024
Q4
$277 Hold
26
﹤0.01% 2687
2024
Q3
$331 Hold
26
﹤0.01% 2682
2024
Q2
$437 Hold
26
﹤0.01% 2637
2024
Q1
$390 Sell
26
-30
-54% -$490 ﹤0.01% 2657
2023
Q4
$840 Hold
56
﹤0.01% 2571
2023
Q3
$785 Hold
56
﹤0.01% 2518
2023
Q2
$580 Hold
56
﹤0.01% 2555
2023
Q1
$518 Sell
56
-41
-42% -$377 ﹤0.01% 2603
2022
Q4
$860 Hold
97
﹤0.01% 2569
2022
Q3
$1K Sell
97
-104
-52% -$860 ﹤0.01% 2577
2022
Q2
$2K Sell
201
-154
-43% -$1.06K ﹤0.01% 2285
2022
Q1
$3K Buy
+355
New +$2.77K ﹤0.01% 2097
2021
Q4
Sell
-1,065
Closed -$18K 2704
2021
Q3
$18K Buy
1,065
+1,020
+2,267% +$16.2K ﹤0.01% 1306
2021
Q2
$1K Sell
45
-16
-26% -$289 ﹤0.01% 2334
2021
Q1
$1K Hold
61
﹤0.01% 2307
2020
Q4
$1K Buy
61
+46
+307% +$964 ﹤0.01% 2204
2020
Q3
$0 Buy
+15
New +$340 ﹤0.01% 2313

Other funds holding URGN